Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a Lot-Based Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility

被引：18

作者：

Aggarwal, S. K. ^{[1
]}

Carter, G. T. ^{[2
]}

Sullivan, M. D. ^{[3
,4
]}

Zumbrunnen, C. ^{[5
]}

Morrill, R. ^{[5
]}

Mayer, J. D. ^{[5
,6
,7
,8
,9
,10
]}

机构：

[1] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY 10016 USA

[2] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA

[3] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA

[4] Univ Washington, Sch Med, Dept Bioeth & Humanities, Seattle, WA USA

[5] Univ Washington, Dept Geog, Seattle, WA 98195 USA

[6] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA

[7] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA

[8] Univ Washington, Dept Med, Seattle, WA USA

[9] Univ Washington, Dept Family Med, Seattle, WA 98195 USA

[10] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA

来源：

AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE | 2013年 / 30卷 / 06期

基金：

美国国家科学基金会;

关键词：

complementary and alternative medicine; cannabinoid medicine; medical cannabis; cannabinopathic medicine; health-related quality of life; symptom management; SF-36; CDC HRQoL-14;

D O I：

10.1177/1049909112454215

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Objectives: To characterize health-related quality of life (HRQoL) in medical cannabis patients. Methods: Short Form 36 (SF-36) Physical Health Component Score and Mental Health Component Score (MCS) surveys as well has CDC (Centers for Disease Control) HRQoL-14 surveys were completed by 37 qualified patients. Results: Mean SF-36 PCS and MCS, normalized at 50, were 37.4 and 44.2, respectively. Eighty percent of participants reported activity/functional limitations secondary to impairments or health problems. Patients reported using medical cannabis to treat a wide array of symptoms across multiple body systems with relief ratings consistently in the 7-10/10 range. Conclusion: The HRQoL results in this sample of medical cannabis-using patients are comparable with published norms in other chronically ill populations. Data presented provide insight into medical cannabis-using patients' self-rated health, HRQoL, disease incidences, and cannabis-related symptom relief.

引用

页码：523 / 531

页数：9

共 28 条

[11]

JIMENEZ A, A JIMENEZS FOLLOW UP

[12] Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment [J].

Leon, Andrew C. ;

Hedeker, Donald ;

Teres, Jedediah J. .

STATISTICS IN MEDICINE, 2007, 26 (01) :110-123

[13] Health status assessment methods for adults: Past accomplishments and future challenges [J].

McHorney, CA .

ANNUAL REVIEW OF PUBLIC HEALTH, 1999, 20 :309-335

[14] The Centers for Disease Control and Prevention's Healthy Days Measures – Population tracking of perceived physical and mental health over time [J].

David G Moriarty ;

Mathew M Zack ;

Rosemarie Kobau .

Health and Quality of Life Outcomes, 1 (1)

[15]

*OFM, INT POSTC EST COUNT

[16]

ONDCP, 2008, 2008 MAR SOURC MAR G

[17]

*OR MED MAR PROGR, OR MED MAR PROGR OMM

[18] The endocannabinoid system as an emerging target of pharmacotherapy [J].

Pacher, Pal ;

Batkai, Sandor ;

Kunos, George .

PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :389-462

[19] Cannabis as a substitute for alcohol and other drugs [J].

Reiman, Amanda .

HARM REDUCTION JOURNAL, 2009, 6

[20]

REINMAN A, 2006, THESIS U CALIFORNIA

← 1 2 3 →